Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1294/week)
Manufacturing
(577/week)
Energy
(393/week)
Technology
(1132/week)
Other Manufacturing
(401/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Amgen
Dec 16, 2020
Amgen To Transfer Listing Of Debt Securities To Nasdaq
Dec 08, 2020
Amgen's Sotorasib Granted Breakthrough Therapy Designation For Advanced Or Metastatic Non-Small Cell Lung Cancer Patients With KRAS G12C Mutation
Dec 05, 2020
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE® Therapy AMG 701 At ASH 2020
Dec 03, 2020
Amgen To Webcast Investor Call At ASH 2020
Nov 30, 2020
World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19
Nov 25, 2020
Amgen To Present At The Evercore ISI Virtual HealthCONx Conference
Nov 23, 2020
Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics
Nov 10, 2020
Amgen To Present At The Cowen 4th Annual IO Summit
Nov 10, 2020
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Nov 09, 2020
Amgen Presents First Clinical Data for AMG 757 at SITC 2020
Nov 04, 2020
Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference
Oct 28, 2020
Amgen Reports Third Quarter 2020 Financial Results
Oct 27, 2020
Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program
Oct 08, 2020
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Oct 05, 2020
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
Sep 20, 2020
Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine
Sep 17, 2020
Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies
Sep 16, 2020
Amgen To Webcast Investor Calls At ESMO 2020
Sep 16, 2020
Amgen To Showcase Data From Oncology Pipeline During ESMO Virtual Congress 2020
Sep 14, 2020
Amgen To Present At The 2020 Bank of America Virtual Global Healthcare Conference
‹‹
Page 4
››
Latest News
Aug 19, 2025
Western States Petroleum Association Names Jodie Muller as New President and CEO
Aug 19, 2025
Woodchuck to Be Featured on “Advancements with Ted Danson” on Bloomberg TV
Aug 19, 2025
Knowles to Participate in Upcoming Conferences
Aug 19, 2025
Battelle Invests $1.2M in STEM Programs at Central Ohio Non-Profits
Aug 19, 2025
SpinLaunch Announces Closing of $30M in Funding to Accelerate the Development of the Meridian Space...
Aug 19, 2025
Sitio Royalties Corp. Stockholders Approve Merger with Viper Energy, Inc.
Aug 19, 2025
Colony Packaging & Machine Is Expanding Converting Capabilities Into The Honeycell Corrugated...
Aug 19, 2025
Prenatal Pesticide Exposure Alters Children’s Brain Development, Impairing Motor Skills
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events